[go: up one dir, main page]

NO990845D0 - Anvendelse av en kombinasjon av amoxycillin og clavulanat til fremstilling av et medikament for behandling av legemiddel-resistent Streptococcus-lungebetennelse - Google Patents

Anvendelse av en kombinasjon av amoxycillin og clavulanat til fremstilling av et medikament for behandling av legemiddel-resistent Streptococcus-lungebetennelse

Info

Publication number
NO990845D0
NO990845D0 NO990845A NO990845A NO990845D0 NO 990845 D0 NO990845 D0 NO 990845D0 NO 990845 A NO990845 A NO 990845A NO 990845 A NO990845 A NO 990845A NO 990845 D0 NO990845 D0 NO 990845D0
Authority
NO
Norway
Prior art keywords
drug
amoxycillin
clavulanate
manufacture
treatment
Prior art date
Application number
NO990845A
Other languages
English (en)
Other versions
NO990845L (no
Inventor
Richard Peregrine Bax
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO990845D0 publication Critical patent/NO990845D0/no
Publication of NO990845L publication Critical patent/NO990845L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO990845A 1996-08-24 1999-02-23 Anvendelse av en kombinasjon av amoksicillin og klavulanat til fremstilling av et medikament for behandling av legemiddel-resistent Streptococcus-lungebetennelse NO990845L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9617780.3A GB9617780D0 (en) 1996-08-24 1996-08-24 Method of treatment
PCT/GB1997/002235 WO1998007424A1 (en) 1996-08-24 1997-08-19 Use of a combination of amoxycillin and clavulanate in the manufacture of a medicament for the treatment drug-resistant streptococcus pneumonia

Publications (2)

Publication Number Publication Date
NO990845D0 true NO990845D0 (no) 1999-02-23
NO990845L NO990845L (no) 1999-04-19

Family

ID=10798919

Family Applications (1)

Application Number Title Priority Date Filing Date
NO990845A NO990845L (no) 1996-08-24 1999-02-23 Anvendelse av en kombinasjon av amoksicillin og klavulanat til fremstilling av et medikament for behandling av legemiddel-resistent Streptococcus-lungebetennelse

Country Status (20)

Country Link
US (2) US6214359B1 (no)
EP (1) EP0938312A1 (no)
JP (1) JP2000516243A (no)
KR (1) KR20000068329A (no)
CN (1) CN1233958A (no)
AR (1) AR008306A1 (no)
AU (1) AU722657B2 (no)
BR (1) BR9711642A (no)
CA (1) CA2264074A1 (no)
CO (1) CO5021201A1 (no)
CZ (1) CZ59299A3 (no)
GB (1) GB9617780D0 (no)
HU (1) HUP0201440A3 (no)
IL (1) IL128644A0 (no)
NO (1) NO990845L (no)
NZ (1) NZ334345A (no)
PL (1) PL331764A1 (no)
TR (1) TR199900413T2 (no)
WO (1) WO1998007424A1 (no)
ZA (1) ZA977564B (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030109503A1 (en) * 1995-06-06 2003-06-12 Smithkline Beecham P.L.C. Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US7250176B1 (en) * 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6565882B2 (en) * 2000-02-24 2003-05-20 Advancis Pharmaceutical Corp Antibiotic composition with inhibitor
US6544555B2 (en) 2000-02-24 2003-04-08 Advancis Pharmaceutical Corp. Antibiotic product, use and formulation thereof
WO2002030392A2 (en) 2000-10-12 2002-04-18 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
US6541014B2 (en) * 2000-10-13 2003-04-01 Advancis Pharmaceutical Corp. Antiviral product, use and formulation thereof
US20020068078A1 (en) 2000-10-13 2002-06-06 Rudnic Edward M. Antifungal product, use and formulation thereof
US20020197314A1 (en) * 2001-02-23 2002-12-26 Rudnic Edward M. Anti-fungal composition
ES2314227T7 (es) * 2002-04-09 2012-11-19 Flamel Technologies Formulacion farmaceutica oral en forma de suspension acuosa de microcapsulas que permiten la liberacion modificada de amoxilicina.
KR100456833B1 (ko) * 2002-08-01 2004-11-10 주식회사 대웅 아목시실린 및 클라불라네이트를 함유하는 유핵정
WO2005009368A2 (en) * 2003-07-21 2005-02-03 Advancis Pharmaceutical Corporation Antibiotic product, use and formulation thereof
JP2006528185A (ja) * 2003-07-21 2006-12-14 アドバンシス ファーマスーティカル コーポレイション 抗生物質製剤、その使用法及び作成方法
AU2004258949B2 (en) 2003-07-21 2011-02-10 Shionogi, Inc. Antibiotic product, use and formulation thereof
WO2005016311A1 (en) * 2003-08-11 2005-02-24 Advancis Pharmaceutical Corporation Robust pellet
WO2005016278A2 (en) 2003-08-12 2005-02-24 Advancis Pharmaceuticals Corporation Antibiotic product, use and formulation thereof
JP5686494B2 (ja) 2003-08-29 2015-03-18 シオノギ インコーポレイテッド 抗生物質製剤、その使用法及び作成方法
AU2004273830B2 (en) * 2003-09-15 2011-03-24 Shionogi, Inc. Antibiotic product, use and formulation thereof
JP2007517039A (ja) * 2003-12-24 2007-06-28 アドバンシス ファーマスーティカル コーポレイション 変性放出製剤の吸収増強
EP1771158A4 (en) * 2004-07-02 2008-03-12 Advancis Pharmaceutical Corp TABLET FOR PULSE DISTRIBUTION
US8357394B2 (en) 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
US8778924B2 (en) * 2006-12-04 2014-07-15 Shionogi Inc. Modified release amoxicillin products
US8299052B2 (en) 2006-05-05 2012-10-30 Shionogi Inc. Pharmaceutical compositions and methods for improved bacterial eradication
US9034410B2 (en) * 2011-08-22 2015-05-19 Thomas J. Vella Whole green coffee bean products and methods of production and use
WO2013173808A2 (en) * 2012-05-17 2013-11-21 Michael Spector Methods for use of lower dose compositions of amoxicillin and clavulanate potassium and devices for use
WO2013173803A2 (en) * 2012-05-17 2013-11-21 Michael Spector Formulations of amoxicillin and clavulanate potassium and methods for using same
JP7629693B2 (ja) 2020-04-28 2025-02-14 小林製薬株式会社 抗菌剤

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ198241A (en) * 1980-09-27 1983-12-16 Beecham Group Ltd Tablet containing amoxycillin and potassium clavulanate
GB9408117D0 (en) * 1994-04-23 1994-06-15 Smithkline Beecham Corp Pharmaceutical formulations
US5753434A (en) 1995-02-10 1998-05-19 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for altering sexual behavior
DZ2028A1 (fr) * 1995-05-03 2002-10-23 Smithkline Beecham Plc Médicaments destinés au traitement d'infections bactériennes en pédiatrie.
NZ337247A (en) * 1995-09-07 2001-05-25 Smithkline Beecham Corp Pharmaceutical tablet formulation comprising 875mg amoxycillin

Also Published As

Publication number Publication date
EP0938312A1 (en) 1999-09-01
GB9617780D0 (en) 1996-10-02
TR199900413T2 (xx) 1999-06-21
CZ59299A3 (cs) 1999-08-11
ZA977564B (en) 1999-02-22
BR9711642A (pt) 2000-10-24
US20020114842A1 (en) 2002-08-22
AU722657B2 (en) 2000-08-10
HUP0201440A2 (en) 2002-09-28
US6214359B1 (en) 2001-04-10
CO5021201A1 (es) 2001-03-27
AR008306A1 (es) 1999-12-29
CN1233958A (zh) 1999-11-03
NO990845L (no) 1999-04-19
CA2264074A1 (en) 1998-02-26
JP2000516243A (ja) 2000-12-05
WO1998007424A1 (en) 1998-02-26
AU4022697A (en) 1998-03-06
IL128644A0 (en) 2000-01-31
NZ334345A (en) 2000-10-27
PL331764A1 (en) 1999-08-02
KR20000068329A (ko) 2000-11-25
HUP0201440A3 (en) 2003-04-28

Similar Documents

Publication Publication Date Title
NO990845D0 (no) Anvendelse av en kombinasjon av amoxycillin og clavulanat til fremstilling av et medikament for behandling av legemiddel-resistent Streptococcus-lungebetennelse
DK0978276T3 (da) Polymerovertrukken tablet omfattende amoxycillin og clavulanat
NO993887D0 (no) Farmasöytiske formuleringer som innbefatter amoksycillin og clavulanat
NO180145C (no) Tannbörste og tildannelse av samme
DK0862431T3 (da) Anvendelse af pædiatrisk farmaceutisk formulering omfattende amoxycillin og clavulanat
FI953838L (fi) Imidatsopyriidineja ja niiden käyttö maha-suolisairauksien hoidossa
CY2009018I1 (el) Φαρμακευτικη συνθεση περιλαμβανουσα πιογλιταζονη και γλιμεπιριδη για χρηση στην θεραπεια του διαβητη
NO942720L (no) 1,5-benzobiazepinderivater og medisinsk anvendelse av disse
DE69415068D1 (de) Mikromotor und Herstellungsverfahren desselben
NO306235B1 (no) Anvendelse av et legemiddel for behandling av artritt
NO975037D0 (no) Preparat omfattende amoxycillin og clavulansyre
PT946175E (pt) Utilizacao de uma combinacao de inibidores de h+, k+ -atpase e de glucocorticiodes no tratamento de polipos nasais
NO991551D0 (no) Anvendelse av tetrahydrobenz(cd)indol-6-karboksamider i fremstilling av medikamenter for forebyggelse av emesis og behandling av seksuell dysfunksjon
NO922998L (no) Perforert drivkrutt, anordning for dets fremstilling og anvendelse av anordningen
DE59410107D1 (de) Chinoxaline und arzneimittel daraus
FI956353L (fi) Farmaseuttiset valmisteet ja niiden käyttö etenkin neurodegeneratiivisten sairauksien hoidossa
DE69318963D1 (de) Drehratensensor und dessen Herstellungverfahren
HK1022626A (en) Use of a combination of amoxycillin and clavulanate in the manufacture of a medicament for the treatment drug-resistant streptococcus pneumonia
NO961046D0 (no) Fremgangsmåte for behandling av pasienter med akutt hjerteinfarkt som ikke gjennomgår trombolytisk behandling med hirudin og acetylsalicylsyre
NO20013464D0 (no) Anvendelse av 3-isoksazolidinoner og hydroksylaminsyrer for behandling av infeksjoner
DE69410123D1 (de) Katheter und herstellungsverfahren
NO990948D0 (no) Anvendelse av PKC-inhibitorer til fremstilling av et medikament for behandling av HTLV-1-infeksjoner
GC0000336A (en) Pharmaceutical formulation comprising amoxycillin and clavulanate for the treatment of drug resistant s.pneumoniae
SE9604300D0 (sv) Therapeutical use and method

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application